1196153-28-2

Basic information

• Product Name: 6-BroMo-2,2-diMethyl-2h-pyrido[3,2-b][1,4]oxazin-3(4h)-one
• Synonyms: 6-BroMo-2,2-diMethyl-2h-pyrido[3,2-b][1,4]oxazin-3(4h)-one
• CAS NO: 1196153-28-2
• Molecular Formula: C₉H₉BrN₂O₂
• Molecular Weight: 257.08396
• Mol File: 1196153-28-2.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 394.9±42.0 °C(Predicted)
• Appearance: /
• Density: 1.533±0.06 g/cm3(Predicted)
• PKA: 10.25±0.40(Predicted)
• CAS DataBase Reference: 6-BroMo-2,2-diMethyl-2h-pyrido[3,2-b][1,4]oxazin-3(4h)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BroMo-2,2-diMethyl-2h-pyrido[3,2-b][1,4]oxazin-3(4h)-one(1196153-28-2)
• EPA Substance Registry System: 6-BroMo-2,2-diMethyl-2h-pyrido[3,2-b][1,4]oxazin-3(4h)-one(1196153-28-2)

Safety Data

• Hazardous Substances Data: 1196153-28-2(Hazardous Substances Data)

Upstream product

• 15128-82-2 3-hydroxy-2-nitropyridine 
• 443956-08-9 6-bromo-2-nitropyridin-3-ol 
• 1303588-10-4 ethyl 2-((6-bromo-2-nitropyridin-3-yl)oxy)-2-methylpropanoate 
• 1373771-93-7 methyl 2-methyl-2-[(2-nitropyridin-3-yl)oxy]propanoate 
• 1373771-94-8 C₁₀H₁₁BrN₂O₅ 
• 600-00-0 ethyl 2-bromoisobutyrate 
• 934758-27-7 2-amino-6-bromo-3-hydroxypyridine 

Downstream Products

• 1303588-12-6 2,2-dimethyl-6-(3-(trifluoromethyl)phenyl)-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine 
• 1303583-09-6 2,2-dimethyl-N-(pyridin-4-yl)-6-(3-(trifluoromethyl)phenyl)-2H-pyrido[3,2-b][1,4]oxazine-4(3H)-carboxamide 
• 1303585-09-2 (S)-6-(3-(3-fluoropyrrolidin-1-yl)phenyl)-2,2-dimethyl-N-(5-methylpyridin-3-yl)-2H-pyrido[3,2-b][1,4]oxazine-4(3H)-carboxamide 
• 1303588-16-0 methyl 3-(2,2-dimethyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)benzoate 
• 1303588-17-1 3-(2,2-dimethyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)benzoic acid 
• 1303588-18-2 (3-(2,2-dimethyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)phenyl)(pyrrolidin-1-yl)methanone 
• 1303588-19-3 2,2-dimethyl-6-(3-(pyrrolidin-1-ylmethyl)phenyl)-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazine 
• 1303584-47-5 2,2-dimethyl-N-(5-methylpyridin-3-yl)-6-(3-(pyrrolidin-1-ylmethyl)phenyl)-2H-pyrido[3,2-b][1,4]oxazine-4(3H)-carboxamide 
• 1303588-20-6 3-(2,2-dimethyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)-N,N-dimethylbenzamide 
• 1303588-21-7 1-(3-(2,2-dimethyl-3,4-dihydro-2H-pyrido[3,2-b][1,4]oxazin-6-yl)phenyl)-N,N-dimethylmethanamine 
• 1303585-44-5 6-(3-((dimethylamino)methyl)phenyl)-2,2-dimethyl-N-(pyridin-3-yl)-2H-pyrido[3,2-b][1,4]oxazine-4(3H)-carboxamide 
• 1373771-91-5 methyl-2-methyl-2-[(2-nitropyridin-3-yl)oxy]propanoate 

Relevant articles and documents

COMPOUNDS AND THEIR USES AS SPLEEN TYROSINE KINASE INHIBITORS

Provided are compounds of Formula (I) which can be used as Syk inhibitors and potently as therapeutic agents against diseases mediated by Syk.

SYK INHIBITORS

The present disclosure a Syk compound inhibitors, including state cancer and inflammation and various disease States thereof in the treatment of relates to the use of. In one aspect a particular embodiment, . given by formula I which is marked as a chemical structure of compound. In formula said, X 1, X 2, X 3, R 2, R 3, R 4, R 5, and Y has described herein is. The present disclosure of a formula I compounds or a pharmaceutically acceptable salt of pharmaceutical compositions including, mediated by Syk and to treat conditions a employing these compounds and compositions further provides a method. (by machine translation)

Rational design and synthesis of novel Syk-kinase inhibitors

Molecular modeling and subsequent synthesis of novel Syk-kinase inhibitors, 7H-pyrrolo[2,3-d]pyrimidine and 1,3,5-triazine derivatives, have been carried out. The best of the obtained compounds demonstrated to inhibit Syk-kinase activity at IC50/sub